These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32990417)

  • 1. Take it personal! Development and modelling study of an indicated prevention programme for substance use in adolescents and young adults with mild intellectual disabilities and borderline intellectual functioning.
    Schijven EP; VanDerNagel JEL; Otten R; Lammers J; Poelen EAP
    J Appl Res Intellect Disabil; 2021 Jan; 34(1):307-315. PubMed ID: 32990417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of an indicated prevention programme for substance use in individuals with mild intellectual disabilities and borderline intellectual functioning: results of a quasi-experimental study.
    Schijven EP; Hulsmans DHG; VanDerNagel JEL; Lammers J; Otten R; Poelen EAP
    Addiction; 2021 Feb; 116(2):373-381. PubMed ID: 32678489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating a selective prevention program for substance use and comorbid behavioral problems in adolescents with mild to borderline intellectual disabilities: Study protocol of a randomized controlled trial.
    Schijven EP; Engels RC; Kleinjan M; Poelen EA
    BMC Psychiatry; 2015 Jul; 15():167. PubMed ID: 26198744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the role of emotional and behavioral problems in a personality-targeted prevention program for substance use in adolescents and young adults with intellectual disability.
    Hulsmans DHG; Otten R; Schijven EP; Poelen EAP
    Res Dev Disabil; 2021 Feb; 109():103832. PubMed ID: 33360962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the Effectiveness of Take it Personal!+ in People With Mild Intellectual Disability or Borderline Intellectual Functioning and Substance Use Disorder: A Multiple Baseline Single-Case Experimental Study.
    Gosens LCF; Poelen EAP; Didden R; de Jonge JM; Schellekens AFA; VanDerNagel JEL; Onghena P; Otten R
    Behav Ther; 2024 Mar; 55(2):331-346. PubMed ID: 38418044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use among individuals with mild intellectual disability or borderline intellectual functioning in residential care: Examining the relationship between drinking motives and substance use.
    Schijven EP; Didden R; Otten R; Poelen EAP
    J Appl Res Intellect Disabil; 2019 Jul; 32(4):871-878. PubMed ID: 30844128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a mindfulness-oriented substance use prevention program for boys with mild to borderline intellectual disabilities: study protocol for a randomised controlled trial.
    Waedel L; Daubmann A; Zapf A; Reis O
    BMC Public Health; 2020 Nov; 20(1):1780. PubMed ID: 33238932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mediating role of substance use motives in the relationship between personality dimensions and alcohol and drug use in adolescents and young adults with mild intellectual disabilities.
    Poelen EAP; Schijven EP; Otten R
    Addict Behav; 2022 Mar; 126():107173. PubMed ID: 34776302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to support peer resistance in adolescents with mild-to-borderline intellectual disability? Intervention development and feasibility.
    Wagemaker E; Salemink E; Huizenga HM; Bart HF; Dekkers TJ; Bexkens A
    J Appl Res Intellect Disabil; 2024 May; 37(3):e13216. PubMed ID: 38403300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating a personalized treatment for substance use disorder in people with mild intellectual disability or borderline intellectual functioning: A study protocol of a multiple baseline across individuals design.
    Gosens LCF; Otten R; Didden R; Poelen EAP
    Contemp Clin Trials Commun; 2020 Sep; 19():100616. PubMed ID: 32743120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment for substance-abusing people with intellectual disabilities: intervening on autonomous motivation for treatment entry.
    Frielink N; Schuengel C; Kroon A; Embregts PJ
    J Intellect Disabil Res; 2015 Dec; 59(12):1168-82. PubMed ID: 26369922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personality dimensions and substance use in individuals with mild to borderline intellectual disabilities.
    Poelen EA; Schijven EP; Otten R; Didden R
    Res Dev Disabil; 2017 Apr; 63():142-150. PubMed ID: 27765413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the serious game 'You & I' in changing mentalizing abilities of adults with mild to borderline intellectual disabilities: a parallel superiority randomized controlled trial.
    Derks S; van Wijngaarden S; Wouda M; Schuengel C; Sterkenburg PS
    Trials; 2019 Aug; 20(1):500. PubMed ID: 31412913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of an e-learning prevention program for substance use among adolescents with intellectual disabilities: A pilot study.
    Kiewik M; VanDerNagel JE; Engels RC; DeJong CA
    Res Dev Disabil; 2017 Apr; 63():160-166. PubMed ID: 27836581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet quality among people with intellectual disabilities and borderline intellectual functioning.
    Gast DAA; de Wit GLC; van Hoof A; de Vries JHM; van Hemert B; Didden R; Giltay EJ
    J Appl Res Intellect Disabil; 2022 Mar; 35(2):488-494. PubMed ID: 34704323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysis.
    VanDerNagel JE; Kiewik M; van Dijk M; Didden R; Korzilius HP; van der Palen J; Buitelaar JK; Uges DR; Koster RA; de Jong CA
    Res Dev Disabil; 2017 Apr; 63():151-159. PubMed ID: 27133469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to peer influence on prosocial behavior in adolescents with Mild Intellectual Disability or Borderline Intellectual Functioning.
    Wagemaker E; van Hoorn J; Bexkens A
    Res Dev Disabil; 2022 Jan; 120():104143. PubMed ID: 34875546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive clinical trauma treatment for children and adolescents with mild intellectual disability or borderline intellectual functioning: A pilot study.
    Ooms-Evers M; van der Graaf-Loman S; van Duijvenbode N; Mevissen L; Didden R
    Res Dev Disabil; 2021 Oct; 117():104030. PubMed ID: 34314951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dental anxiety in patients with borderline intellectual functioning and patients with intellectual disabilities.
    Fallea A; Zuccarello R; Calì F
    BMC Oral Health; 2016 Nov; 16(1):114. PubMed ID: 27809836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance use prevention program for adolescents with intellectual disabilities on special education schools: a cluster randomised control trial.
    Kiewik M; VanDerNagel JE; Kemna LE; Engels RC; DeJong CA
    J Intellect Disabil Res; 2016 Mar; 60(3):191-200. PubMed ID: 26631986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.